MSD (MRK. N) 2024 Q4 revenue of $15.62 billion, the market expectations of $15.45 billion, the same period last year $14.63 billion.
MSD (MRK. N): 2025 revenue is expected to be $64.10 billion - $65.60 billion, and the market is expected to be $67.37 billion.
Merck (MRK. N) dived before the market, falling more than 2.7%.
Shares of Merck (MRK. N) fell 6 percent, touching their lowest level since March 15.